123732-04-7

Basic information

• Product Name: 4-N-HEPTYLOXYBROMOBENZENE
• Synonyms: P-BROMO(HEPTYLOXY)BENZENE;4-N-HEPTYLOXYBROMOBENZENE;1-BROMO-4-N-HEPTYLOXYBENZENE;1-(4-BROMOPHENOXY)HEPTANE;4-BROMO-(HEPTYLOXY)BENZENE
• CAS NO: 123732-04-7
• Molecular Formula: C₁₃H₁₉BrO
• Molecular Weight: 271.19
• Mol File: 123732-04-7.mol
• Article Data: 16

Chemical Properties

• Boiling Point: 314.9°Cat760mmHg
• Flash Point: 131.5°C
• Appearance: /
• Density: 1.185g/cm³
• Vapor Pressure: 0.00733mmHg at 25°C
• Refractive Index: 1.511
• CAS DataBase Reference: 4-N-HEPTYLOXYBROMOBENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-N-HEPTYLOXYBROMOBENZENE(123732-04-7)
• EPA Substance Registry System: 4-N-HEPTYLOXYBROMOBENZENE(123732-04-7)

Safety Data

• Safety Statements: 24/25
• Hazardous Substances Data: 123732-04-7(Hazardous Substances Data)

Usage

General Description

4-N-Heptyloxybromobenzene is an organic chemical compound with the chemical formula C12H17BrO. It is classified as an alkylaryl bromide, consisting of a benzene ring substituted with a 4-heptyloxy group and a bromine atom in the para position. 4-N-HEPTYLOXYBROMOBENZENE is commonly used as an intermediate in the synthesis of various organic compounds, particularly in the production of pharmaceuticals and agrochemicals. It is known for its strong aromatic odor and is considered to be a flammable liquid. 4-N-Heptyloxybromobenzene is also used in research and development, where its unique properties and reactivity make it a valuable building block for the creation of new chemical compounds.

InChI:InChI=1/C9H9NO2/c1-11-8-4-2-3-5-9(8)12-7-6-10/h2-5H,7H2,1H3

Upstream product

• 106-41-2 4-bromo-phenol 
• 4282-40-0 1-Iodoheptane 
• 629-04-9 1-Bromoheptane 

Downstream Products

• 176967-77-4 4-n-heptyloxyphenylmagnesium bromide 
• 1018958-64-9 C₂₆H₂₈N₂O₃ 
• 29147-88-4 4-(heptyloxy)benzonitrile 
• 1260872-35-2 4-(4-(heptyloxy)phenyl)piperidine 
• 1443792-30-0 tert-butyl 4-(4-(heptyloxy)phenyl)-4-hydroxypiperidine-1-carboxylate 
• 1443792-26-4 tert-butyl 4-(4-(heptyloxy)phenyl)-3-oxopiperazine-1-carboxylate 
• 1443791-80-7 (Z)-4-(heptyloxy)-N’-hydroxybenzimidamide 
• 1443792-27-5 1-(4-(heptyloxy)phenyl)piperazin-2-one 
• 1443788-24-6 (S)-2-(4-(tert-butyl)benzamido)-3-(4-(3-(4-(heptyloxy)phenyl)-1,2,4-oxadiazol-5-yl)phenyl)propanoic acid 
• 1443791-84-1 (S)-methyl 2-(4-(tert-butyl)benzamido)-3-(4-(((4-(heptyloxy)benzimidamido)oxy)carbonyl)phenyl)propanoate 
• 1443791-83-0 (S)-methyl 2-(4-(tert-butyl)benzamido)-3-(4-(3-(4-(heptyloxy)phenyl)-1,2,4-oxadiazol-5-yl)phenyl)propanoate 
• 1443792-03-7 methyl 2-((tert-butoxycarbonyl)amino)-3-(4-(5-(4-(heptyloxy)phenyl)thiazol-2-yl)phenyl)propanoate 
• 1443792-02-6 methyl 2-((tert-butoxycarbonyl)amino)-3-(4-(5-(4-(heptyloxy)phenyl)thiazol-2-yl)phenyl)acrylate 
• 1443792-00-4 (S)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-(2-(4-(heptyloxy)phenyl)thiazol-4-yl)phenyl)propanoate 

Relevant articles and documents

Synthesis and biological evaluation of biarylamide derivatives as inhibitors of phagocytosis in macrophages

-

FUSED PYRIMIDINE COMPOUNDS AS KCC2

The invention concerns compounds of Formula (I): (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R7 and ring A have any of the meanings hereinbefore defined in the description; process for their preparation; pharmaceutical compositions containing them and their use in treating KCC2 mediated diseases.

CYCLOHEXADIENE FULLERENE DERIVATIVES

The invention relates to novel fullerene derivatives, to methods for their preparation and educts or intermediates used therein, to mixtures and formulations containing them, to the use of the fullerene derivatives, mixtures and formulations as organic semiconductors in, or for the preparation of, organic electronic (OE) devices, especially organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to OE, OPV and OPD devices comprising, or being prepared from, these fullerene derivatives, mixtures or formulations.